Open original FDA record ↗Recall record
- FDA identifier
- Z-0194-2020
- Company in FDA record
- TIDI PRODUCTS
- FDA record creation date
- Oct 25, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Not meeting design specifications.
Source facts
- Action
- On April 5th the firm sent letters to their customers stating the following: Next Steps: 1. Ensure that all caregivers and users of the Posey Connected Twice-As-Tough (TAT) Cuffs (nos. 2796 and 2797) are made aware of this Recall Notice. 2. Refer to the enclosed TAT Cuff Lot Number List (Attachment 1) and check your inventory to determine if your facility has any affected units. 3. Destroy affected TAT Cuff(s) by following the enclosed TAT Cuff Destruction Instructions (Attachment 2). Dispose of damaged products per your facilitys policy for BIOHAZARDOUS material. 4. Complete the enclosed Customer Response and Proof of Destruction Form and return this form to the TIDI Products Regulatory Department. 5. Product Replacement Product shipment will resume on or around April 12, 2019. Replacement orders will be fulfilled as Customer Response and Proof of Destruction Forms are received. Note: If you have zero inventory of affected product, please enter 0 in the Quantity section and return form as required. Distribution of this Recall Notice: Please distribute this Recall Notice to appropriate individuals within your organization and to any organization where the potentially affected devices were transferred or sold. Please maintain awareness of this notice and resulting action for a minimum of two years to ensure effectiveness of this corrective action. In cases where customers opt not to proceed with completion of the recall requirements described above, TIDI Products cannot accept any responsibility for safety related issues or legal liabilities caused by the failure to respond to this Recall Notice. We regret any inconvenience that this Recall Notice may cause. Note: Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Additional Comment If you have any further questions or require assistance completing the Cust
- Initiated
- 2019-04-12
- Root cause
- Process control
- Terminated
- 2020-07-22
- Distribution
- AK, AR, CA, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MN, MO, MS, MT, NC, NH, NJ, NM, NY, PA, SC, TN, TX, UT, VA, VT, WI, and WV CANADA, FRANCE, and THE NETHERLANDS
- Recall number
- Z-0194-2020
- Recall status
- Terminated
- CDRH record ID
- 171784
- FDA record created
- 2019-10-25
- Recall event number
- 82534